BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22012715)

  • 21. [The association of hepatitis B virus genotype and the basal core promoter mutation in Qidong, China].
    Jin Y; Zhu Y; Chen TY; Guo X; Zhang J; Wang JB; Chen WZ; Qian GS; Tu H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):511-5. PubMed ID: 20678441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.
    Fang ZL; Sabin CA; Dong BQ; Wei SC; Chen QY; Fang KX; Yang JY; Huang J; Wang XY; Harrison TJ
    J Gen Virol; 2008 Nov; 89(Pt 11):2882-2890. PubMed ID: 18931087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subgenotype D5, BCP and MHR mutations in hepatic complications among hepatitis B virus infected patients from Orissa, India.
    Panigrahi R; Biswas A; Banerjee A; Singh SP; Panigrahi MK; Roque-Afonso AM; Das HS; Mahapatra PK; Chakrabarti S; Chakravarty R
    Infect Genet Evol; 2012 Dec; 12(8):1622-9. PubMed ID: 22820088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
    Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
    Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
    Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
    Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
    Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient.
    Skelton M; Kew MC; Kramvis A
    Virus Res; 2012 Jan; 163(1):59-65. PubMed ID: 21889961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection.
    Chu CM; Lin CC; Chen YC; Jeng WJ; Lin SM; Liaw YF
    Br J Cancer; 2012 Dec; 107(12):2010-5. PubMed ID: 23079574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.
    Mathews P; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Lyu H; Jaffee E; Zheng L; Yu E; Lee YJ
    Ann Surg Oncol; 2013 Apr; 20(4):1216-22. PubMed ID: 23104706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
    Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea.
    Song BC; Kim H; Kim SH; Cha CY; Kook YH; Kim BJ
    J Med Virol; 2005 Jan; 75(1):13-9. PubMed ID: 15543574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.
    Chen QY; Hu YL; Wang XY; Harrison TJ; Wang C; Hu LP; Yang QL; Ren CC; Jia HH; Fang AZ
    Int J Med Sci; 2019; 16(7):990-997. PubMed ID: 31341412
    [No Abstract]   [Full Text] [Related]  

  • 33. Frequency and clinical significance of core promoter and precore region mutations in Tunisian patients infected chronically with hepatitis B.
    Ouneissa R; Bahri O; Alaya-Bouafif NB; Chouaieb S; Ben Yahia A; Sadraoui A; Hammami W; Filali N; Azzouz MM; Mami NB; Triki H
    J Med Virol; 2012 Nov; 84(11):1719-26. PubMed ID: 22997074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China.
    Cao Z; Bai X; Guo X; Jin Y; Qian G; Tu H
    Arch Virol; 2008; 153(10):1807-12. PubMed ID: 18726170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon.
    Atsama Amougou M; Marchio A; Bivigou-Mboumba B; Noah Noah D; Banai R; Atangana PJA; Fewou Moundipa P; Pineau P; Njouom R
    J Viral Hepat; 2019 Sep; 26(9):1086-1093. PubMed ID: 31106515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
    Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between hepatitis B virus genotype, BCP/Pre-C region mutations and risk of hepatocellular carcinoma in Guangxi Zhuang Autonomous Region].
    Zheng D; Deng W; Huang T; Li X; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jul; 36(7):725-9. PubMed ID: 26564702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
    Lee JH; Hong SP; Jang ES; Park SJ; Hwang SG; Kang SK; Jeong SH
    J Med Virol; 2015 Jun; 87(6):993-8. PubMed ID: 25712861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.